CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the changes to F...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...
Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...